183
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Nonalcoholic fatty liver disease and the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: the hidden danger

, , , , ORCID Icon, , & show all
Pages 369-373 | Received 26 Oct 2020, Accepted 27 Dec 2020, Published online: 18 Jan 2021

References

  • Canlas KR, Branch MS. Role of endoscopic retrograde cholangiopancreatography in acute pancreatitis. World J Gastroenterol. 2007;13(47):6314–6320.
  • Ahmed M, Kanotra R, Savani GT, et al. Utilization trends in inpatient endoscopic retrograde cholangiopancreatography (ERCP): a cross-sectional US experience. Endosc Int Open. 2017;5(4):E261–E271.
  • Bor R, Madácsy L, Fábián A, et al. Endoscopic retrograde pancreatography: When should we do it? World J Gastrointest Endosc. 2015;7(11):1023–1031.
  • Chen JJ, Wang XM, Liu XQ, et al. Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years. Eur J Med Res. 2014;19:26.
  • Dumonceau JM, Andriulli A, Elmunzer BJ, Mariani A, European Society of Gastrointestinal Endoscopy, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. [updated 2014 Jun]. Endoscopy. 2014;46(9):799–815.
  • Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909–918.
  • Banks PA, Bollen TL, Dervenis C, Acute Pancreatitis Classification Working Group, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111.
  • Ding X, Zhang F, Wang Y. Risk factors for post-ERCP pancreatitis: A systematic review and meta-analysis. Surgeon. 2015;13(4):218–229.
  • Wang AY. Medications and Methods for the Prevention of Post-ERCP Pancreatitis. Gastroenterol Hepatol (NY). 2017;13:188–191.
  • Tarnasky PR, Palesch YY, Cunningham JT, et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 1998;115(6):1518–1524.
  • Wong LL, Tsai HH. Prevention of post-ERCP pancreatitis. World J Gastrointest Pathophysiol. 2014;5(1):1–10.
  • Cote GA, Elmunzer BJ. Nonsteroidal Anti-inflammatory Drugs for Prevention of Post-ERCP Pancreatitis: Sooner Rather Than Later during ERCP? Gastroenterology. 2016;151(5):1027–1028.
  • Bertolotti M, Lonardo A, Mussi C, et al. Nonalcoholic fatty liver disease and aging: epidemiology to management. World J Gastroenterol. 2014;20(39):14185–14204.
  • Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263–2273.
  • Nseir W, Abu-Rahmeh Z, Tsipis A, et al. Relationship between Non-Alcoholic Fatty Liver Disease and Breast Cancer. Isr Med Assoc J. 2017;19:242–245.
  • Kwak MS, Yim JY, Yi A, et al. Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women. Dig Liver Dis. 2019;51(7):1030–1035.
  • Nseir W, Artul S, A, Rajab S, et al. M. Association between non-alcoholic fatty liver disease and hospitalized patients with community-acquired pneumonia. Isr Med Assoc J. 2017;19:198.
  • Mahamid M, Abu-Elhija O, Yassin T, et al. Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp. Can J Gastroenterol Hepatol. 2017;2017:1–5.
  • Xu C, Qiao Z, Lu Y, et al. Influence of Fatty Liver on the Severity and Clinical Outcome in Acute Pancreatitis. PLoS One. 2015;10(11):e0142278.
  • Reddy SK, Zhan M, Alexander HR, et al. Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders. WJG. 2013;19(45):8301–8311.
  • Brody H. Fatty liver disease. Nature. 2017;551(7681):S85–S85.
  • Le MH, Devaki P, Ha NB, et al. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. PLoS One. 2017;12(3):e0173499.
  • Deenadayalu VP, Blaut U, Watkins JL, et al. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study. J Clin Gastroenterol. 2008;42(10):1103–1109.
  • Fujisawa T, Kagawa K, Hisatomi K, et al. Obesity with abundant subcutaneous adipose tissue increases the risk of post-ERCP pancreatitis. J Gastroenterol. 2016;51(9):931–938.
  • Kim EJ, Cho JH, Oh KY, et al. The risk factors for moderately severe and severe post-endoscopic retrograde cholangiopancreatography pancreatitis according to the revised Atlanta classification. Pancreas. 2017;46(9):1208–1213.
  • Cotton PB, Garrow DA, Gallagher J, et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70(1):80–88.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.